| Test |
Specimen Type |
Quantity Required |
Average TAT |
Remarks |
| Acylcarnitine profile |
Heparin blood |
4 mL |
1 month |
Qualitative results with interpretation, if applicable |
| Adenosine deaminase |
Pleural fluid, peritoneal/ascitic fluid, pericardial
fluid, CSF |
4 mL, (CSF: 1 mL) |
1 week |
Send frozen specimen |
| Amino acid profile by HPLC |
Heparin blood or spot urine |
2 mL blood
10 mL urine |
2 weeks |
Prior arrangement necessary |
| Delta aminolaevulinic acid |
Spot urine (protect from light) |
10 mL |
1 week |
- |
| Broad spectrum Metabolic screening by GCMS |
Spot urine |
10 mL |
2 weeks |
- |
| Faecal porphyrins by HPLC |
Spot faeces (protect from light) |
5 g |
2 weeks |
For Follow up of patients with increased urinary
porphyrins or porphobilinogens only)
Special arrangement |
| Fluoride & Dibucaine number of Cholinesterase |
Clotted blood |
3 mL |
2 days |
- |
| Mucopolysaccharide pattern by electrophoresis |
Spot urine |
10 mL |
2 weeks |
- |
| Oligosaccharide profile by HPTLC |
Spot urine |
10 mL |
2 weeks |
- |
| Organic acids profile by GCMS |
Spot urine |
10 mL |
2 weeks |
Qualitative with interpretation |
| Orotic acid by GCMS |
Spot urine |
10 mL |
2 weeks |
Quantitative |
| PBG |
Spot urine (protect from light) |
10 mL |
1 day |
Quantitative |
| Porphyrins profile by HPLC |
Spot urine (protect from light) |
20 mL |
2 week |
- |
| Porphyrins, Total |
Spot urine (protect from light) |
20 mL |
1 week |
Quantitative |
| Toxicology screening (Broad spectrum) by HPLC |
Spot urine/ clotted blood/ gastric lavage/ drug samples |
Urine (30 mL)/ Clotted blood (4 mL) |
1 day |
Qualitative |